Sirtuins are an ancient family of NAD + -dependent deacylases connected with the regulation of fundamental cellular processes including metabolic homeostasis and genome integrity. We show the existence of a hitherto unrecognized class of sirtuins, found predominantly in microbial pathogens. In contrast to earlier described classes, these sirtuins exhibit robust protein ADP-ribosylation activity. In our model organisms, Staphylococcus aureus and Streptococcus pyogenes, the activity is dependent on prior lipoylation of the target protein and can be reversed by a sirtuin-associated macrodomain protein. Together, our data describe a sirtuin-dependent reversible protein ADP-ribosylation system and establish a crosstalk between lipoylation and mono-ADP-ribosylation. We propose that these posttranslational modifications modulate microbial virulence by regulating the response to host-derived reactive oxygen species.
In Brief
Oxidative stress has been recognized as a critical factor in human disease, aging, and the immune system function. Rack et al. report a structural and biochemical analysis of a sirtuin/macrodomain system modulating the oxidative stress response in pathogenic microorganisms via reversible protein ADP-ribosylation.
Accession Numbers 5A35 5A3A 5A3B 5A3C
INTRODUCTION
Sirtuins are a diverse enzyme family of NAD + -dependent protein deacylases that control a variety of cellular processes including cell cycle progression, maintenance of genome integrity, and metabolic homeostasis (Asher and Schibler, 2011; Choi and Mostoslavsky, 2014) . The overall structure of sirtuins is comprised of a highly conserved Rossmann fold and a more diverse zinc coordinating domain (Yuan and Marmorstein, 2012) . The reaction mechanism is initialized by activation of NAD + , followed by a nucleophilic attack and release of nicotinamide. In the case of deacylation, a reactive imidate intermediate is formed that can undergo base-exchange with nicotinamide, thereby inhibiting reaction progression (reviewed in Sauve, 2010) . Phylogenetically, the sirtuin family can be divided into five classes (I-IV and U, see Figure 1A ) (Frye, 2000; Greiss and Gartner, 2009) , and a correlation between sirtuin class and substrate preference was recently suggested (Dö lle et al., 2013; He et al., 2012) . For example, human SIRT1, a class I sirtuin, is most efficient at deacetylation, whereas SIRT5, belonging to class III, has highest activity toward succinylation (Du et al., 2011; Feldman et al., 2013) . Although sirtuins appear to be primarily deacylases, several studies have suggested that some also possess protein ADPribosyltransferase activity (Haigis et al., 2006; Kowieski et al., 2008) . Posttranslational ADP-ribosylation influences various cellular processes, such as transcription, chromatin organization, nitrogen fixation, and DNA repair, via modification of different acceptor proteins Feijs et al., 2013; Nordlund and Hö gbom, 2013) .
Macrodomains are evolutionary widespread ADP-ribosebinding domains (Till and Ladurner, 2009 ) that have the potential to reverse sirtuin reactions either by hydrolysis of ADP-ribosylated protein substrates , or by deacylating O-acyl-ADP-ribose (Chen et al., 2011; Peterson et al., 2011) .
In this study, we report on the identification of a distinct class of sirtuins (SirTMs) found primarily in pathogenic microorganisms and show that these function as protein ADP-ribosyl transferases. Members of this sirtuin class are genetically linked to a specific subclass of macrodomain proteins, which reverse the sirtuin catalyzed ADP-ribosylation. Our structural and biochemical analysis suggest that SirTMs possess class-specific features that may explain the preference for protein ADP-ribosylation. Moreover, we show that in Staphylococcus aureus and Streptococcus pyogenes the sirtuin-mediated ADP-ribosylation is dependent on another posttranslational modification-lipoylation. We propose that a crosstalk between these two types of protein modifications is important for the response of microbial pathogens to oxidative stress, a potent host defense mechanism.
RESULTS

Identification of a Distinct Class of Sirtuins
By analyzing available genomic data, we have identified a phylogenetically distinct class of microbial sirtuins ( Figure 1A ) (Chen et al., 2011 and this study). At the primary sequence level, members of this clade are characterized by a set of short sequence motifs, which are only distantly related to the intraand interclass sirtuin motifs described by Frye (for details see Figure S1 and Table S1 ) (Frye, 2000) . The most surprising difference is the replacement of the absolutely conserved HG motif containing the catalytic H residue by QG ( Figure S1C ). These microbial sirtuins are further characterized by their genetic linkage to a subclass of macrodomain proteins. Hence, we designate this class of macrodomain-linked sirtuins as ''class M'' and their members as ''SirTMs.'' In bacteria the genes for SirTMs and the associated macrodomains lie adjacent within the same operon. In fungi the two open reading frames (ORFs) are fused to encode a single macrodomain-SirTM polypeptide that we termed macrodomain-fused SirTM 1 (Mfs1). SirTMs are predominantly present in pathogenic organisms including strains in the bacterial Clostridiaceae, Enterococcaceae, Lachnospiraceae, Spirochaetaceae, and Veillonellaceae families and fungal Aspergillus, Candida, Entamoeba, Fusarium, and Phytophthora genera, among others ( Figure 1A ).
Composition of the Extended SirTM Operon in
Lactobacillales and Staphylococcaceae Bacterial SirTMs and their macrodomain partners are present as either independent operons or part of extended operons. One type of extended operon can be found in Lactobacillales and Staphylococcaceae, where the SirTMs are flanked by the ORFs of a glycine cleavage system H-like (GcvH-L) protein and a lipoate-protein ligase homolog (LplA2) ( Figure 1B ). LplAs are key enzymes for scavenging of the organosulfur cofactor lipoate (an alternative to the de novo synthesis of lipoate) and therefore are essential for virulence of microbial pathogens (Spalding and Prigge, 2010) . Canonical GcvH is a component of the multienzyme glycine cleavage system (GCS) involved in glycine detoxification and one-carbon metabolism (Spalding and Prigge, 2010) , where it serves as a reaction intermediate shuttle via a conserved lipoylated lysine. The genome of Staphylococcus aureus contains both a canonical GcvH associated with the GCS operon and a non-canonical form present in the extended pathogenspecific operon (Table 1) . Streptococcus pyogenes lacks the GCS system (Spalding and Prigge, 2010 and this study) and its
A B C Figure 1. Macrodomain-Associated Sirtuins Form a Distinct Class within the Sirtuin Family
(A) Unrooted phylogram illustrating the relationship between the known sirtuin classes (I-IV and U) and sirtuins found associated with macrodomains. The latter form a distinct class among the sirtuins (highlighted in red). Human sirtuins (SIRT1-7) are highlighted in blue and sirtuins used in this study in orange. Schematic genome arrangements of the macrodomain-linked sirtuins are given underneath the tree. Details regarding class M-specific motifs can be found in Figure S1 and Table S1 . (B) Schematic overview and organization of the extended SirTM operons. In addition to the sirtuin/macrodomain, the operon encodes a glycine cleavage system H-like (GcvH-L) protein and lipoate protein ligase A (LplA2). The operon is commonly associated with the ORFs of homologs of the Old Yellow Enzyme (OYE) and bacterial luciferase-like monooxygenase (LLM) family (i, ii, and v) . Less frequently, association with only one of the two ORFs can be observed (iii, iv, and vi) . The encoded proteins are indicated on top of the schemes and the gene loci of S. aureus (sav0322-sav0327) and S. pyogenes (spyM50865-spyM50870) are indicated underneath the corresponding schemes.
(C) Scheme of the functional relationship between the extended operon components.
genome encodes only the SirTM-associated form of GcvH. This suggests that GcvH-L supports a GCS-independent function. In addition, the SirTM operon is associated with two uncharacterized oxidoreductases, one of which exhibits similarities to a flavin-utilizing bacterial luciferase-like monooxygenases (LLM; Pfam: PF00296) and the other to an Old Yellow Enzyme (OYE; Pfam: PF00724) type NADH:flavin oxidoreductase ( Figure 1B ).
The LplA2/GcvH-L Pair: An Operon-Specific Lipoylation System To explore the molecular and biological functions of the SirTMs, we performed a detailed biochemical characterization of the proteins from S. pyogenes (SpySirTM) and S. aureus (SauSirTM) as representatives of their respective families. Since these sirtuins are part of an operon encoding the LplA2/GcvH-L pair, we hypothesized that they catalyze delipoylation of GcvH-L. Therefore, we first assessed whether the operon-encoded LplA2 can lipoylate GcvH-L, as seen for the canonical LplA/ GcvH pairs from S. aureus and Escherichia coli that served as positive controls. Indeed, both operonal LplA2s efficiently transferred lipoic acid (LA) onto GcvH-L as assessed by immunoblot (IB) using a specific anti-lipoylation antibody (Figures 2A, 2B, and S2B) . Mutagenesis showed that the lipoyl-attachment site is Lys56 within the conserved Ex(2)Kx(10)G motif (Fujiwara et al., 1991; Spalding and Prigge, 2009 ). Since SauGcvH-L appears to be weakly lipoylated in the absence of LplA2, we investigated whether the recombinant GcvH-L can be co-expressionally modified by the endogenous E. coli ligase. First, we performed lipoylation assays testing the ability of SauLplA1, 2 or EcoLplA to modify the corresponding GcvH proteins ( Figure S2C ). While SauLplA2 shows selectivity for GcvH-L, SauLplA1 appears to be indiscriminative toward both S. aureus GcvHs. Both enzymes, however, exhibit negligible activity toward EcoGcvH. In contrast, EcoLplA readily modifies all three GcvHs. To test whether these results are transferable to the expression conditions, we supplemented cultures upon induction of protein expression with LA ( Figure 2C ). Indeed, this increased the co-expressional lipoylation of GcvH-L. The effect could further be enhanced via inhibition of protein synthesis by kanamycin (doubly treated GcvH-L is termed ''in vivo lipoylated'' in subsequent experiments).
Together these results suggest that LplA2 is a specific lipoate ligase for GcvH-L and that the LplA2/GcvH-L pair shares several characteristics with the LplA/GcvH pairs of the GCS.
SirTMs Lack Protein Deacylase Activity
Next, we tested whether SauSirTM was able to reverse the lipoylation of SauGcvH-L. We performed the assay with in vitro and in vivo lipoylated SauGcvH-L and showed that SauSirTM failed to delipoylate SauGcvH-L ( Figure 3A ). On the other hand, incubation with lipoamidase (Lpa) from Enterococcus faecalis readily removed the lipoyl moiety ( Figure S2D ).
Since lipoate is a limiting factor for the growth of some pathogenic bacteria, we hypothesized that the SirTMs could act as scavenging enzymes by delipoylating other endogenous or host-derived proteins. To assess this, we performed delipoylation assays using total protein extracts from S. aureus, E. coli, and Figure 3D ). Again, SirTMs showed no activity against biotinyl-BCCP. These observations suggest that SirTMs do not participate in lipoyl or biotinyl scavenging/removal. This is further supported by our observation that LplA2 can utilize lipoamide, which mimics protein bound LA, as substrate for GcvH-L modification and therefore release of the free LA by scavenging appears not to be required for LplA2 function ( Figure S2E ). We extended our deacylation analyses to two other prominent lysine modifications in bacteria-acetylation and succinylationusing IBs with modification-specific pan-antibodies as detection tools. To exclude interference from the endogenous bacterial sirtuin, CobB, we performed the deacetylation assays on the cell extracts of CobB-deficient E. coli (BL21(DE3)DCobB) (Figure 3E) . Our results show that SirTMs are unable to remove acetylation from endogenous proteins, whereas the control enzymes S. aureus CobB (SauCobB) and human SIRT2 show activity against some of the acetylated cellular proteins. We also performed two additional in vitro deacetylation assays using acetylated histones and p53-derived peptides, both considered to be generic sirtuin targets. Under the assay conditions, neither SirTM displayed any deacetylation activity toward acetylated p53 ( Figure 3F ) or penta-acetylated histone H3 ( Figure 3G ). In contrast, both control enzymes, SIRT2 and SauCobB, showed robust deacetylation activity toward these targets. Desuccinylation activity was tested using a fluorescence succinyl-peptide assay as well as non-enzymatically succinylated histone octamers as substrates. Again, we could not detect any activity for the SirTMs against these targets (Figures S3B and S3C) .
Taken together, these results suggest that the pathogenic SirTMs lack deacylation activity.
Class M Sirtuins Are Lipoylation-Dependent ADP-Ribosyltransferases While deacylation is the predominant activity of sirtuins (Du et al., 2009) , several studies have reported that some sirtuins also exhibit ADP-ribosyltransferase activity (Haigis et al., 2006; Kowieski et al., 2008) . Therefore, we decided to test whether SauSirTM could ADP-ribosylate the purified operon proteins in the presence of 32 P-labeled NAD + . We resolved the reaction products by SDS-PAGE and analyzed them by autoradiography and IB. Among the tested proteins, only SauGcvH-L was modified by SauSirTM ( Figure 4A ). Furthermore, we observed that prior lipoylation of SauGcvH-L greatly stimulated ADP-ribosyl transfer ( Figure 4A , right panel). We further confirmed the presence of ADP-ribosyl group on GcvH-L by the treatment with phosphodiesterase NUDT16 that can hydrolyze protein bound ADP-ribose (Palazzo et al., 2015) ( Figure S4A ).
Crosstalk between Lipoylation and ADP-Ribosylation
To confirm the dependence of GcvH-L mono-ADP-ribosylation (MARylation) on lipoylation, we performed lipoylation assays using wild-type (WT) and lipoylation-deficient GcvH-L mutants followed by MARylation reactions using SpySirTM and SauSirTM ( Figure 4B ). Since only the lipoylated WT GcvH-L was MARylated we concluded that the reaction is dependent The mutations were chosen in analogy to the canonical LplA/GcvH pair of E. coli where they interfere both with the lipoate adenylation and the subsequent lipoate transfer (Fujiwara et al., 2010) .
(B) Mutations of lipoylation motif residues within GcvH-L impair the lipoate transfer reaction. Mutation of Lys56 interferes with lipoyl attachment, whereas Glu53 is important for recognition by LplA2 (Fujiwara et al., 1991 (Fujiwara et al., , 2010 . Control reactions were carried out using the canonical LplA/GcvH pairs of S. aureus (SauGcvH, SauLplA1) and E. coli (EcoGcvH, EcoLplA).
(C) SauGcvH-L and SpyGcvH-L were expressed in the presence and absence of lipoic acid supplementation. In addition, protein synthesis of some samples was interrupted by supplementation with kanamycin 1 hr prior to culture harvesting. The effect of the additives on GcvH-L lipoylation was assessed by immunoblot. For further characterization of the LplA2/GcvH-L pair, see Figure S2 .
on prior lipoylation. To rule out that free LA stimulates the reaction, we performed a MARylation assay following incubation with LA and lipoamide ( Figure S4B ). MARylation was only observed following covalent linkage of lipoic acid to GcvH-L, thus strengthening the notion that the protein modification rather than free LA is the determining factor. To distinguish between an allosteric stimulation of ADP-ribosylation or a more direct involvement in the reaction, we supplemented MARylation reactions of unmodified GcvH-L with lipoylated peptides ( Figure S4C ). While lipoylated GcvH-L was readily modified, neither of the lipoylated peptides stimulated ADPribosylation activity toward the unmodified GcvH-L, thus suggesting that ADP-ribosylation can only occur as consequence of a prior lipoylation of the same GcvH-L molecule. Analysis of the peptides incubated in the presence of SirTM and NAD + by thin layer chromatography (TLC) showed no incorporation of ADP-ribose (ADPr) into the peptides, hence excluding a competition reaction between peptide and unmodified GcvH-L ( Figure S4D ). To assess whether the SirTM-mediated ADPribosylation is specific for GcvH-Ls, we performed MARylation assays using the lipoylated canonical GcvHs from S. aureus and E. coli ( Figure 4C ) as well as biotinylated BCCP as substrates ( Figure S4E ). Strikingly, SirTMs show absolute selectivity for the lipoylated GcvH-L. Altogether, these data show that lipoylated, full-length GcvH-L is required as substrate in the ADP-ribosylation reaction.
To rule out that the observed ADP-ribosylation is attributed to an indirect non-enzymatic process or represents a weak side Control samples with in vivo lipoylated SauGcvH-L were treated as ''in vitro'' samples, however, without addition of SauLplA2 and LA. (B) Delipoylation and debiotinylation assay performed on S. aureus cell extracts. For lipoylation only, dihydrolipoamide S-acetyltransferase (DLAT) could be detected, whereas BCCP, biotin protein ligase (BPL), and pyruvate carboxylase (PC) could be identified as biotinylated. For assays on E. coli cell lysates, see Figure S3A . (C) Delipoylation and debiotinylation assays were performed as in (B), but using human 293T cell extract. For lipoylation only DLAT could be detected, whereas PC, 3-methylcrotonyl-CoA carboxylase (MCC) and propionyl-CoA carboxylase (PCC) could be identified as biotinylated. (D) Debiotinylation assay using recombinant, in vitro modified BCCP as substrate. Free biotin was removed from the initial biotinylation reaction by passing it twice over a desalting column. (E) Deacetylation activity of SirTMs was tested on BL21(DE3)DCobB lysates. Human SIRT2 (isoform 2) and SauCobB were used as positive controls. (F) Deacetylase activities of SauSirTM and SpySirTM against a p53-derived peptide were assessed using the SIRT-Glo assay (Promega). Data are background corrected means ± SD of triplicate measurements. (G) Deacetylase activity of sirtuins (compare to F) was tested against penta-acetylated histone H3 (modified residues: K4, K9, K14, K18, and K23). (E) Comparison of the ADP-ribosyl transferase activities of human SIRT4DMTS and T. brucei TmSir2 with SpySirTM. The activities were assessed on previously described and herein identified substrates: glutamate dehydrogenase (GDH), histone H1 (H1), and GcvH-L for SIRT4, TmSir2 and SpySirTM, respectively. Deacetylase activity of TmSir2 was controlled using a p53-derived peptide as substrate ( Figure S3D ). (F) ADP-ribosyl hydrolase assays were performed with the operon macrodomains (SpyMacro and SauMacro). Control reactions were carried out with the closely related macrodomain proteins MacroD1 (human) and YmdB (E. coli) or in the absence of a macrodomain protein (cntr). (G) Identification of the Macro reaction product by TCL. Protein bound 32 P-ADPr is immobile under the TLC condition (origin), whereas released 32 P-ADPr comigrates with the PARP1/PARG (human) control. (H) GST-pulldown assay using GST-fused SauGcvH-L as bait. Prior to pull-down SauGcvH-L was either lipoylated or Lpa treated to define the modification status. The molar ratio of proteins (GcvH-L/GST:operonal) was 1:1. Recombinant GST was used as negative control and binding was monitored by IB.
(legend continued on next page) reaction, we performed a number of validation assays. First, we confirmed that 32 P-NAD + is stable under the assay condition, thus ruling out that hydrolyzed NAD products could cause nonenzymatic ADP-ribosylation ( Figure S4F ). We also performed a time course experiment comparing WT SpySirTM with a catalytically inactive mutant (N118A) (Yuan and Marmorstein, 2012) . While the WT enzyme transferred the radiolabel in a time-dependent manner, no transfer was observed for the catalytic mutant ( Figure 4D ). We could further confirm that a genuine catalytic activity was required for the ADPr transfer by performing the assays in presence of the general sirtuin inhibitors nicotinamide and Tenovin-6 ( Figure S4G ). While Tenovin-6 inhibited the GcvH-L MARylation, nicotinamide did not significantly affect the reaction. The latter finding is surprising and might indicate that the active site is protected from base-exchange and thus from inhibition by nicotinamide (Sauve, 2010) . Next, we compared the activity of SpySirTM with human SIRT4 and Trypanosoma brucei TbSir2 that both have described activity as ADP-ribosyl transferases (Fahie et al., 2009; Haigis et al., 2006) . While SpySirTM robustly ADP-ribosylates GcvH-L, neither SIRT4 nor TbSir2 exhibits comparable activity on their described targets (glutamate dehydrogenase and histone H1, respectively) using the same enzyme and substrate concentrations ( Figure 4E ).
Together, these results provide evidence for a highly specific ADP-ribose transferase activity of SirTMs that depends on the prior lipoylation of the target protein GcvH-L.
Operon Macrodomains Specifically Reverse SirTM-Mediated ADP-Ribosylation As some macrodomain-containing proteins are known to hydrolyze protein ADP-ribosylation Slade et al., 2011; Sharifi et al., 2013) , we assessed the ability of the operon-encoded macrodomains to remove the SirTM-mediated MARylation of the GcvH-L. Strikingly, the operon macrodomains (SpyMacro and SauMacro) catalyzed efficiently the modification reversal, as indicated by the loss of radiolabel from GcvH-L, whereas the homologous protein de-MARylating macrodomains from human and E. coli (MacroD1 and YmdB, respectively) did not exhibit this activity ( Figures 4F and S4H ). We further characterized the reaction product of the Macro reaction by TLC. While protein bound ADPr is immobile, the Macro cleavage product co-migrates with ADPr released in the human PARP1/PARG control reaction ( Figure 4G ) (Slade et al., 2011) . The activity of the operonal macrodomains is not absolutely dependent on the lipoylation present on GcvH-L, as revealed by testing the de-MARylation reactions using Lpa-delipoylated GcvH-L as a substrate ( Figure S4I ). However, GST-pull down assays showed that the macrodomain interacts with GcvH-L in a strictly lipoylation-dependent manner ( Figure 4H ), thus suggesting lipoylationdependence in vivo.
Since GcvH-L ADP-ribosylation is part of a coupled reaction, we tested the labeling efficiency within the assays. To this end, all operon reactions were performed consecutively with samples taken after completion of each reaction and subsequently analyzed by electrophoretic gel shift. While lipoylation increased the electrophoretic mobility (Ali et al., 1990) , MARylation led to a distinct retention ( Figure 4I ). We estimate that under our assay conditions, $50% of the GcvH-L protein is lipoylated and 5% of the initial substrate becomes ADP-ribosylated. Importantly, MARylation can be fully reversed by addition of SauMacro.
Overall, we conclude that the operon-encoded Macro protein specifically reverses SirTM-dependent ADP-ribosylation and its reaction product is ADP-ribose as seen for other macrodomain proteins Sharifi et al., 2013) . We propose that the pathogenic SirTM/Macro pair coevolved as an ON/OFF switch for the GcvH-L ADP-ribosylation.
SpySirTM Structure Reveals an Unexpected Catalytic Residue To gain further insight into the SirTM catalyzed ADP-ribosylation, we determined the crystal structure of SpySirTM, both in the ligand-free form as well as bound to ADPr or NAD + . The overall fold for these three structures is identical with a low root-meansquare deviation (RMSD) (0.29-0.31 Å ). The models contain residues 3-292 (residues 7-10 are not visible in the electron density maps) and follow a typical sirtuin fold comprised of a large Rossmann fold and a small bipartite zinc coordinating domain (Figure 5A ; , with the exception of slight readjustment of the loop region between b6 and a14 as well as following b7 ( Figure 5B ). This movement allows the highly conserved Asn258 to interact with the 2 0 -and 3 0 -OH groups of the adenine ribose, while the imidazole group of the relatively poorly conserved His259 rotates by $110 to allow stacking against the adenine moiety. In addition, the pyrophosphate is coordinated by the class-specific GVGx[NT]TP motif (residues 229-235), found in the b6-a14 loop.
The amide moiety of nicotinamide is bound by direct and water-mediated polar contacts with Ala34, Phe42, Ala119, and Asp120, thus positioning the nicotinamide and the distal ribose in a conformation similar to that observed for TmSir2 (Figure S5B ). The conserved Asn118 coordinates a highly ordered water molecule, which was proposed to facilitate the initial hydrolysis of nicotinamide from NAD + (Zhao et al., 2004) . On the a-face of the ribose the 3 0 -OH group interacts with the absolutely conserved residue Gln137, which replaces the catalytic histidine found in all other sirtuin classes. Gln137 makes further contact with the N d atom of the similarly conserved residue Arg192
(I) ADP-ribosylation band-shift assay performed with (de)modified SauGcvH-L. SauGcvH-L was incubated consecutively with LplA2, SirTM, and Macro under standard assay conditions (lipoylation 30 min, MARylation 1 hr, and de-MARylation 1 hr). Samples were taken after each reaction step and untreated SauGcvH-L served as control. Under the electrophoretic condition, lipoylation leads to an increased migration (<), while MARylation results in a discrete retention (z). MARylation was confirmed by its reversibility by Macro treatment. See also Figure S4 .
( Figure 5B ). Together, these interactions appear to be necessary for the correct positioning of the nicotinamide ribose, and by extension, the GcvH-L substrate. To assess the importance of these residues, we performed MARylation assays with WT and mutant SpySirTM. While WT SpySirTM modified SpyGcvH-L, a mutation of Asn118, Gln137, or Arg192 dramatically decreased the catalytic activity ( Figure 5C ). Interestingly, substitution of Gln137 with the general base histidine, found in other sirtuins, also leads to a complete loss of activity, suggestive of a distinct catalytic mechanism for class M sirtuins.
Relationship between MARylation and Lipoylation
Sites on GcvH-L To gain further insight into the requirements for the SirTM-mediated ADP-ribosylation, we characterized the ADPr attachment side on the GcvH-L. Since the lipoyl group contains a reactive 1,2-dithiolan moiety that, hypothetically, could be modified in a manner similar to cysteines, we incubated doubly modified SauGcvH-L with WT and catalytically inactive Lpa to remove the lipoyl moiety ( Figure 5D ). While WT Lpa removed the lipoylation, SauGcvH-L remained radiolabeled, thus indicating that the lipoyl moiety is not the ADPr attachment site. Next, we tested whether Macro could remove ADP-ribosylation from acidic residues as shown for many of the characterized macrodomain enzymes using MARylated human PARP1 and PARP3 proteins as model substrates (Sharifi et al., 2013; Slade et al., 2011) . In these assays, both operonal macrodomains showed comparable activity to human MacroD1 suggesting that they act on acidic residues ( Figure S5C ). Accordingly, we performed a mutagenesis analysis of highly conserved aspartates and glutamates within GcvH-L (Figures 5E, S6A, and S6B). All tested mutations showed robust lipoylation, but importantly E24A and D27A exhibited near and total loss of modification. Only extended exposure revealed slight ADP-ribosylation of E24A, whereas no ADPr incorporation could be detected for D27A. These findings suggest that Asp27 is the likely ADPr attachment side, but further indicates involvement of Glu24 in the ADP-ribosylation mechanism. It is worth noting, that the presence of an acidic residue in position of Asp27 is absolutely conserved in pathogenic GcvH-L proteins, but it is also common among canonical GcvH proteins. On the other hand, Glu24 is only present in GcvH-L homologs (Figures 5F, S5D, and S6B).
To better understand the spatial relationship between ADP-ribosylation and lipoylation attachment sites, we determined the crystal structure of SpyGcvH-L. The structure contains residues 1-110 and is comprised of a barrel-sandwich hybrid formed by two b sheets flanked by short a helices (Table 2) (C) The activity of selected SpySirTM mutants was tested in a MARylation assay. SpySirTM WT in the presence and absence of GcvH-L lipoylation were used as controls. For detailed information about the residues see Figure S1 and Table S1 .
(D) Delipoylation assays were performed with in vivo lipoylated SauGcvH-L (see also Figure 2C ). The protein was MARylated with SauSirTM and subsequently delipoylation was performed using WT or catalytically impaired (S259A) lipoamidase.
(E) MARylation assays were performed using selected GcvH-L mutants. To distinguish the effects of E24A and D27A short (S) and extended (E) autoradiographic exposures are shown. ranging from 0.575-1.14 Å ), the most striking differences observed in SpyGcvH-L are (1) the position of the b4/b5 loop (residues 38-40), which diverges from the consensus path by $6 Å as a consequence of the presence of Arg72 in the b8 strand (a position usually occupied by Val or Ile); and (2) the absence of a C-terminal a helix ( Figure S5D ). Intriguingly, the missing a helix, which is held in place by electrostatic contacts between four conserved residues in the canonical GcvHs, would occlude residues implicated in ADP-ribose attachment in SpyGcvH-L (Glu24 and Asp27) (Figures S5E and S6B) . The absence of the steric hindrance imposed by this a helix may be a prerequisite for the GcvH-L/SirTM interaction and thus could account for the high substrate specificity of SirTMs.
SirTM Function Is Linked to Redox Response
We observed that the operonal oxidoreductase SpyOYE shows robust, strictly lipoylation-dependent interaction with GcvH-L, as judged by in vitro pull-down assays ( Figure 4H ). The observation of a direct interaction with an oxidoreductase prompted us to further investigate whether SirTM activity could be linked to the oxidative stress response in vivo. For this, we utilized the pathogenic fungus Candida albicans as a model system and created a homozygous deletion strain of the gene encoding the SirTM homolog (mfs1, orf19.2285) ( Figure S7 ). Upon inactivation of Mfs1 activity, fungal growth improved in the presence of high doses of hydrogen peroxide, as assayed on agar plates ( Figure 6A ). Improved growth was observed in four independent mfs1D 
where / is measured density for reflections with indices hkl.
R free has the same formula as R cryst , except that calculation was made with the structure factors from the test set.
clones ( Figure 6A ), and the same trend was observed when we analyzed growth in response to oxidative stress in suspension cultures ( Figure 6B ). This finding suggests that Mfs1 modulates the oxidative stress response in C. albicans.
DISCUSSION
In the present study, we have identified a distinct class of sirtuins (SirTMs). This class is highly conserved and occurs either as part of a bacterial operon or, in fungi, as a macrodomain-SirTM fusion enzyme.
SirTMs: Not Deacylases, but ADP-Ribosyl Transferases
Our results show that SirTMs do not possess any appreciable deacylation activity against a number of different endogenous and host-derived substrates (Figures 3 and S3 ). In accordance with the functional analysis, our sequence and structural analysis revealed the absence of a catalytic histidine residue, crucial for the proposed deacylase mechanism and found in all other hitherto described sirtuins (Sauve, 2010; Yuan and Marmorstein, 2012) and that may explain the apparent absence of deacylation activity in SirTMs. On the other hand, our data show a robust MARylation activity by SirTMs that is highly specific for the GcvH-L, a protein encoded by the same operon. Furthermore, the SirTM-dependent ADP-ribosylation is specifically and efficiently reversed by the pathogenic macrodomain proteins. Collectively, our data argue for protein ADP-ribosyl transferase as the primary activity of SirTMs.
Operon Proteins in the Response to Oxidative Stress
The data presented here strongly support the notion that ADPribosylation of GcvH-L is dependent on its prior lipoylation. The operon-encoded LplA2/GcvH-L pair is only distantly related to the canonical GCS, but nonetheless, the catalytic and the lipoate attachment residues are conserved in the proteins from pathogenic species. While S. pyogenes naturally lacks a canonical GCS, S. aureus possesses a complete GCS as well as the operon-encoded LplA2/GcvH-L pair (Spalding and Prigge, 2010 and this study). Interestingly, our analysis showed that the canonical SauLplA1 can modify both GcvH proteins, while SauLplA2 appears to have selectivity toward GcvH-L (Figure S2C ). This may indicate that lipoylation of GcvH-L is the preferred target for LA attachment under conditions of operon activation.
Transcriptome and proteome analysis revealed that activation of this operon occurs under conditions of oxidative stress (Nobre and Saraiva, 2013; Palazzolo-Ballance et al., 2008; Surmann et al., 2014) , consistent with an involvement in the oxidative stress response. This is further supported by several observations: (1) LA was shown to possess antioxidant properties in models of oxidative stress (Packer et al., 1995) , (2) it was reported that Mycobacterium tuberculosis utilizes two components of the a-ketoacid dehydrogenase complex in a lipoyldependent defense against the oxidative immune response of the host (Bryk et al., 2002) , and (3) the operon is genetically associated with the putative oxidoreductases LLM and OYE. Both enzymes are as yet uncharacterized. However, their families have been implicated in detoxification of ROS (Chaiyen et al., 2012; Odat et al., 2007) , and we show that the oxidoreductase OYE directly interacts with lipoylated GcvH-L. These findings suggest that GcvH-L could act as carrier protein for the ROS scavenging lipoyl moiety and/or as a substrate for oxidoreductases. Evidence obtained from the fungal pathogen C. albicans in this study points toward an involvement of SirTMs in the oxidative stress response. Accordingly, in C. albicans the expression of mfs1 is very low under standard growth conditions, and the gene is only expressed to a considerable degree upon oxidative stress either chemically induced (Enjalbert et al., 2009) or by exposure to human blood (Fradin et al., 2003) . Collectively, these results are consistent with a primary cellular function of Mfs1 when cells encounter oxidative stress, such as upon host interactions. In line with a specific function in host-pathogen interactions, engulfment of S. aureus by host (human) cells led to an induction of the macrodomain encoded in the SirTM operon (Surmann et al., 2014) .
Combining these observations together with the high prevalence of the SirTM operon in known pathogenic microorganisms and the importance of lipoate scavenging for microbial pathogenesis (Spalding and Prigge, 2010), we propose that the SirTM operon or SirTM-macrodomain fusion proteins in eukaryotic microbes modulate the response of microbial pathogens to oxidative stress and host-pathogen interactions. 
Crosstalk between Lipoylation and ADP-Ribosylation
Here, we present the direct evidence for a connection between protein lipoylation and ADP-ribosylation. Collectively our data suggest that lipoylation of GcvH-L is a prerequisite for its MARylation. Since ADP-ribosylation is a known modification influencing protein function and interactions , it is interesting to speculate that the MARylation state of GcvH-L might regulate the availability of the lipoyl moiety for redox reactions. This idea is supported by our finding that the ADPr attachment site is in close structural proximity to the lipoylation site. Moreover, the specific upregulation of the operonal macrodomain in S. aureus after internalization into human cells (Surmann et al., 2014) indicates that under these conditions de-MARylation of GcvH-L prevails. Collectively, these data suggest that the ADP-ribosylation inhibits the interaction of the oxidoreductase with GcvH-L when it is not required. In other words, ADP-ribosylation of GcvH-L might be acting to keep the response ''off'' under non-stress conditions.
EXPERIMENTAL PROCEDURES
The experimental procedures are described in detail in the Supplemental Information. These procedures include plasmid construction, protein expression and purification, structure determination, interaction and enzymatic activity assays, cell culture condition, as well as phylogenetic analysis. Below is a simplified description of the major experimental procedures. The amino acid sequences of the operon proteins can be accessed through UniProtKB: under Q99WQ2, P67343, Q99WQ0, and Q99WP9 (S. aureus) as well as A2REC0, A2REC1, A2REC2, and A2REC3 (S. pygones).
Protein Expression and Purification
Recombinant proteins were expressed in Rosetta (DE3) cells and affinity purified either by Ni 2+ -NTA chromatography (QIAGEN) or using glutathione Sepharose 4B (GE Life Sciences). All proteins were dialyzed over night against protein buffer (50 mM TrisHCl [pH 8], 200 mM NaCl, 1 mM DTT) (see Supplemental Information for further details). Protein purity was assessed by SDS-PAGE ( Figure S2A ).
Enzymatic Assays
Lipoylation reactions were carried out using 1 mM LplA and 2 mM target protein.
Reactions were incubated for 30 min at 30 C before analysis by immunoblot or further processing. Control reactions were carried out in the absence of LplA. Deacetylation of p53-derived peptide was tested with the SIRT-Glo assay kit (Promega) according to the manufacturer's recommendations using 6 nM sirtuin per reaction. Deacetylation of synthetic penta-acetylated histone H3 (Active Motif) was carried out as described earlier (Rack et al., 2014) .
Delipoylation of in vitro and in vivo lipoylated GcvH-L was carried out in delipoylation buffer (50 mM TrisHCl [pH 8], 200 mM NaCl, 10 mM MgCl 2 , 1 mM DTT) using 1 mM recombinant sirtuin, 1 mM GcvH1, and 1 mM NAD + . Reactions were incubated at 30 C for 2 hr.
ADP-ribosylation reactions were carried out using 1 mM sirtuin, 1 mM target protein, 2 mCi 32 P-NAD + , and 5 mM unlabeled NAD + . Reactions were incubated for 60 min at 30 C before analysis by immunoblot or further processing.
De-ADP-ribosylation assay was carried out using 1 mM radiolabeled GcvH-L and 1 mM macrodomain protein. The reactions were incubated for 1 hr at 30 C.
For further details regarding enzymatic assays, see Supplemental Information.
Crystallization Recombinant proteins were concentrated to a concentration of $14 mg/ml. Crystals were obtained by hanging-drop vapor diffusion at 293 K by mixing 120 nl protein solution with 30 nl seed stock and 150 nl precipitant. For the ADPr and NAD + complexes, native crystals were soaked with 1 mM ligand in mother liquor for 20 hr and 10 min, respectively. The crystals were cryoprotected in a solution of mother liquor plus 20% ethylene glycol and vitrified by submersion in liquid nitrogen for data collection.
A single SpyGcvH-L crystal grew at 293K using the sitting-drop vapor diffusion. The crystal was cryoprotected in a solution of precipitant plus 15% PEG400 (see Supplemental Information for further details).
X-Ray Data Collection, Processing, Structure Determination, Refinement, and Analysis X-ray diffraction data were collected using synchrotron radiation ( Table 2 ). The CCP4 software suite (Winn et al., 2011) was used to process all datasets, including integration, scaling, molecular replacement, density modification, automated model building, and structure refinement. COOT (Emsley and Cowtan, 2004) was used for manual model building and autoSHARP (Vonrhein et al., 2007) for locating the Se atoms in the Apo selenomethionine derivate as well as for refinement and initial phase calculation. The processing, phasing, and final refinement statistics are presented in Table 2 (see Supplemental Information for details).
All structural alignment were generated in COOT and figures prepared with PyMOL (Molecular Graphics System, Version 1.3 Schrö dinger, LLC) using DSSP (Joosten et al., 2011) for secondary structure assignment.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been deposited in the Protein Data Bank under ID codes PDB: 5A35, 5A3A, 5A3B, 5A3C. Table S2 . Figure S1 (E) Comparison of residues involved in tethering the C-terminal α-helix, which is absent in GcvH-L, to the core structure. The coloration is as in (D) and helix α1, which contains the residues involved in ADP-ribose attachment (GcvH-L, highlighted), is shown in dark blue.
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Electrostatic interaction are given as dotted lines. Note, the α-helix/core structure interaction minimally consists of a structural motif composed of four conserved residues ([YF], H, [ST] and Y) that is extended by non-conserved interactions in the cases of the bovine and pea
GcvHs. Residue numbers correspond to endogenous full-length proteins as shown in the alignment in Figure S6B . and BtaGcvH). For sequence accession numbers see Table S2 . 
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Figure S7
Supplemental Tables   Table S1 . Proposed interactions for class M defining residues of SpySirTM (related to Figure 1 and 5). (a) The spacing between the first two cysteine residues coordinating the zinc ion is specific for class M sirtuins.
Motif Residues in SpySirTM Role
All other classes contain a Cx(2)C motif.
Supplemental Experimental Procedures Sample analysis and antibodies
Reactions for analysis were stopped by adding LDS sample buffer and incubation for 5 min at 90°C.
Subsequently the samples were resolved by SDS-PAGE and either vacuum dried for autoradiography or transferred onto a PVDF membrane. Immunoblot analyses were carried out using primary and secondary antibodies as indicated. Proteins were detected by enhanced chemiluminescence (Pierce).
Antibodies used in this study: Mouse monoclonal hexahistindine antibody (Clonetech), rabbit 
Plasmid construction
The construction of the human MacroD1, PARG, PARP1 E988Q and SIRT2, E. coli YmdB, E.
faecalis Lpa and T. brucei TbSir2 expression vectors were described previously , Chen et al., 2011 , Fahie et al., 2009 , Rack et al., 2014 , Slade et al., 2011 , Spalding and Prigge, 2009 and 2, SpyLplA2 and SpyOYE were transferred into pDEST17, and the sequence of SauCobB was transferred into pDEST42 via gateway cloning. The coding sequences of human SIRT4ΔMTS
(removing residues 1 -28 which encode the MTS (Haigis et al., 2006) and adding a C-terminal GSG linker and hepta-histidine tag) was introduced into pET9d, the sequences of SauBCCP and SpyBCCP were introduced into pET9H 3 (adding a N-terminal double-tryptophan for UV quantitation), the sequences SauGcvH-L, SpyGcvH-L and SpyLLM were introduced into pET21a and the sequences of SauMacro, SpyMacro, SauSirTM and SpySirTM were introduced into pET28 via restriction based cloning. The coding sequences of SauBPL and SpyBPL were introduced into pNH-TrxT (Savitsky et al., 2010) via ligation independent cloning.
All indicated mutations were introduced via PCR based site-directed mutagenesis.
In silico analysis of the sirtuin domain of SirTMs and GcvH-L
Selection of representative sequences of formerly described sirtuin classes is based on the work of Greiss and Gartner (Greiss and Gartner, 2009 (Sievers et al., 2011) with bacterial single domain sirtuins. Sequences for tree construction were aligned using JalView 2.8.0b1 (Waterhouse et al., 2009) and the Clustal Omega program implemented therein. An unrooted phylogram was generated by neighbor-joining method using SplitTrees4 V4.13.1 (Huson and Bryant, 2006) . Confidence level of the class clades was estimated to be ≥ 98.8% by bootstrapping using 10000 replicates.
Multiple sequence alignments of GcvH(-L) proteins and sirtuins were generated using JalView 2.8.0b1 and the MAFFT L-INS-I algorithm implemented therein (Katoh et al., 2005) . Comparative sirtuin domain alignment was generate by initially aligning full-length protein using MAFFT L-INS-I and extracting SirTM homology regions. The extracted sequences were re-aligned using Clustal
Omega. Alignment representations were created with ALINE (Bond and Schuttelkopf, 2009 ).
Sequences details and accession numbers are given in Table S2 .
Bacteria strains and culture
For generation of E. coli cell extracts BL21 ( For generation of S. aureus cell extracts SH1000 cells were grown on BHI agar plates. BHI medium was inoculated with a single colony and grown overnight at 37°C and 150 rpm. The overnight culture was diluted 1:100 in fresh BHI medium and culture was allowed to grow for 2 hr. Cells were harvested by centrifugation and washed twice in extraction buffer before resuspention in 1 mL extraction buffer. Partial lysis was achieved by incubation with BugBuster protein extraction reagent (Novagen) and lysozyme for 2 hr at RT on a rotating wheel. Unlysed cell and cellular debris was removed by centrifugation at 20000 xg for 30min at 4°C.
Candida strains and culture
The opening reading frame encoding amino acids 1-492 of the Candida albicans macrodomain-fused SirTM (mfs1), orf19.2285 (C2_07280W), was deleted in the BWP17 strain background (ura3::imm434/ura3::imm434 iro1/iro1::imm434 his1::hisG/his1::hisG arg4/arg4). Selection markers ARG4 and URA3 were used to create a homozygous deletion mutant by homologous recombination.
The marker-matched wild type strain (DAY286) was used as the control in all experiments.
Confirmation of homozygous deletion by Southern blot analysis is shown in Figure S7 . Strains were maintained in 15% glycerol (v/v) at -80°C. Working stocks were streaked onto YPDUri agar plates (1% yeast extract, 2% peptone, 2% glucose, 2% agar, 80 μg/ml uridine), strains grown at 30°C for 2-3 days, and then plates maintained at room temperature. For experiments testing the sensitivity to hydrogen peroxide (H 2 O 2 ), strains were inoculated into YPDUri media over night at 30°C, 200 rpm and grown to saturation. Cultures were then diluted to OD 600 0.5 and 2.5 μl dropped onto YPDUri control or H 2 O 2 -containing plates, followed by incubation at 30°C for 3 days. Alternatively, broth H 2 O 2 susceptibility assays were performed in a 96-well microplate, following a method described by (Park et al., 2008) , with modification. Overnight C. albicans cultures were harvested by centrifugation 
Protein expression and purification
Recombinant proteins were expressed in Rosetta (DE3) cells grown in LB medium supplemented with 2 mM MgSO 4 and appropriate antibiotics at 37°C to OD 600 0.6. In addition, expression cultures of lipoamidase were supplemented with 2% glucose (w/v), 5 mM potassium acetate and 5 mM sodium succinate. Expression was induced with 0.4 mM IPTG and 5 μM zinc acetate in case of zinccontaining enzymes. Cells were grown at 30°C and harvested 4 hr post-induction by centrifugation.
Lipoamidase expression was carried out at 18°C overnight. SeMET SpySirTM protein was produced as above but using minimal medium and SeMET growth medium (SelenoMet Medium Base plus SelenoMet Nutrient Mix, Molecular Dimensions) supplemented with 50 mg/mL of SeMET after 40 min of inoculation. The SeMET SpySirTM protein was expressed at 30 °C for 18 hr.
Recombinant His-tagged proteins were purified by Ni 2+ -NTA chromatography (Qiagen) according to the manufacturer's protocol using the following buffers: all buffer contained 50 mM TrisHCl (pH 8) and 500 mM NaCl; additionally, the lysis/binding buffer contained 10 mM imidazole, the washing buffer contained 30 mM imidazole, and the elution buffer contained 500 mM imidazole.
Recombinant GST-tagged proteins were purified using Glutathione Sepharose 4B (GE Life Sciences) according to the manufacturer's protocol using the following buffers: lysis/binding/washing PBS containing 1 mM DTT and elution 50 mM TrisHCl (pH 8), 200 mM NaCl containing 10 mM reduced glutathione and 1 mM DTT.
All proteins were dialyzed over night against 50 mM TrisHCl (pH 8), 200 mM NaCl, 1 mM DTT.
Proteins intended for crystallization underwent affinity purification over a HisTrap HP column (GE Healthcare) followed by size exclusion chromatography using a HiLoad Superdex 75 column (GE Healthcare). Proteins were concentrated using Vivaspin 20 columns (GE Healthcare).
Lipoylation assays
Lipoylation reactions were carried out in lipoylation buffer [50 mM TrisHCl (pH 8), 200 mM NaCl, 5 mM ATP, 2.4 mM lipoic acid, 1 mM MgCl 2 , 1 mM DTT] using 1 μM LplA and 2 μM target protein or in a 1:2 molar ratio if higher concentrations were required for subsequent reactions. Reactions were incubated for 30 min at 30°C before analysis by immunoblot or further processing.
Substrate specificity of SauLplA2 was assessed by incubation of 1 µM of SauGcvH-L with increasing concentrations of lipoic acid or lipoamide (0.24, 2.4, 24 or 240 µM) in the presence of 1 µM enzyme at 37°C for 30 min. Control reactions were carried out at highest substrate concentration in the absence of SauLplA2. All samples were analyzed by immunoblot.
For in vivo lipoylation of GcvH-L, Rosetta (DE3) cells were grown as described above. Upon induction cultures were supplemented with 100 μM lipoic acid and grown for 3 hr at 30°C. Further protein synthesis was inhibited by addition of 150 μg/ml kanamycin and cells were incubated for an additional 60 min. Control reactions were supplemented with solvent instead of lipoic acid. Samples were taken before induction and kanamycin addition and at the end of the incubation period to evaluate the success of in vivo lipoylation. All samples were analyzed by immunoblot.
Biotinylation assay
BCCP biotinylation was carried out in biotinylation buffer [50 mM TrisHCl (pH 8), 200 mM NaCl, 1 mM DTT, 1 mM MgCl2, 300 µM biotin and 5 mM ATP] at 30°C for 1 hr using 2 µM BCCP and 1 µM BPL. Reactions were stopped by twice purifying the protein over PD SpinTrap G25 (Ge Healthcare) columns. Purified proteins were used as substrates for debiotinylation or ADPribosylation reaction (see below).
Deacylation assays
Delipoylation of in vitro and in vivo lipoylated GcvH-L was carried out in deacylation buffer [50 mM
TrisHCl (pH 8), 200 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, 1 mM NAD + ] using 1 μM recombinant sirtuin and 1 μM GcvH-L. Reactions were incubated at 30°C for 2 hr.
Debiotinylation was carried out analogously using purified, biotinylated BCCP as substrate (see above). All reactions were stopped by addition of LDS sample buffer.
Deacylation of bacterial and human cell extracts (40 µg) was carried out in deacylation buffer for 2 hr at 30°C. Reactions were supplemented with 2 µM recombinant sirtuin as indicated. Lpa control reaction were carried out in PBS using 1 µg crude Lpa purification. All reactions were stopped by addition of LDS sample buffer.
Delipoylation using Lpa was carried out by mixing the initial lipoylation reaction or in vivo lipoylated GcvH-L in lipoylation buffer (1/3 final vol.) with 10x PBS (1/10 final vol.) and 1µg crude Lpa purification. The volume was adjusted with dH 2 O and the reaction incubated for 2 hr at 30°C. All reactions were stopped by addition of LDS sample buffer.
Deacetylation of synthetic penta-acetylated histone H3 (Active Motif) was carried out as described earlier (Rack et al., 2014) . Briefly, deacetylation was carried out in deacylation buffer [50 mMTrisHCl (pH 8), 137 mM NaCl, 2.7 mM KCl and 10 mM MgCl 2 , 0.5 mM DTT] using 2 µM purified sirtuin, 1 mM NAD + and 1 µM penta-acetylated histone H3. Reactions were incubated at 30°C for 2 hr and stopped by addition of LDS sample buffer.
Desuccinylation of a fluorogenic succinyl-peptide was tested with the Fluorogenic SIRT5 assay kit (BPS bioscience) according to the manufacturer's recommendations using 300 ng sirtuin per reaction.
For desuccinylation Xenopus-derived histone octamers were non-enzymatically succinylated as described earlier (Wagner and Payne, 2013) . Briefly, succinylation reaction were carried out in succinylation buffer [50 mM TrisHCl (pH 8 at 37°C), 150 mM NaCl, 0.5 mM succinyl-CoA] using 3 µM histone octmaers as substrate. Reactions were incubated for 6 hr at 37°C at 400 rpm in an
Eppendorf Thermomixer and subsequently stored on ice until further use. Desuccinylation was carried out as described for histone deacetylation using 1 µM succinylated histone octamers as substrate.
ADP-ribosylation assays
ADP-ribosylation reactions were carried out in MARylation buffer [50 mM TrisHCl (pH 8), 200 mM NaCl, 1 mM MgCl 2 , 1 mM DTT] using 1 μM sirtuin, 1 μM target protein, 2 μCi 32 P-NAD + and 5 μM unlabeled NAD + . A 1:1 molar ratio was used if higher concentrations were required for subsequent reactions. Reactions were incubated for 60 min at 30°C before analysis by autoradiography and immunoblot or further processing. For kinetic studies the incubation time was varied as indicated.
ADP-ribosylation reactions using purified, biotinylated BCCP (see above) as substrate were carried out analogously.
For inhibitor studies 6 mM Tenovin-6 (Axon Medchem) stock solution was prepared in 18% DMSO (v/v) and 50 mM HCl. Further dilutions were prepared with 18% DMSO. Final DMSO concentration in the assays was 3%. Nicotinamide (Sigma) solutions were prepared in dH 2 O. All reaction components (including inhibitors) were mix and incubated for 10 min at RT before starting the reaction by addition of 2 μCi 32 P-NAD + and 10 µM unlabeled NAD + .
For reaction containing free lipoic acid or lipoamide both compounds were dissolved in DMSO and diluted to 2% DMSO (v/v) in the final assay conditions. For reaction containing peptides (custom synthesized by Alta Biosciences (now Abington Health); sequences are ±5 residues of the indicated modification site and two C-terminal tryptophan residues were added for UV quantitation, the Ntermini are acetylated and the C-termini amide modified) peptides were dissolved in DMSO and diluted to 5 µM and 2% DMSO (v/v) in final assay conditions.
For ADP-ribosylation comparison reaction were carried out in MARylation buffer using 5 µg target protein (lipoylated SpyGcvH-L, glutamate dehydrogenase (Sigma) and histone H1 (New England Biolabs) respectively), 1.5 µM sirtuin, 20 µM unlabeled NAD + and 4 µCi 32 P-NAD + .
Reaction were carried out at 37°C for 2 hr. Reactions were stopped with LDS sample buffer and analyzed by autoradiography and immunoblot.
De-ADP-ribosylation assays
De-ADP-ribosylation was carried out in [50 mM TrisHCL (pH 8), 200 mM NaCl, 1 mM MgCl 2 ,
1mM DTT] out using 1 µM radiolabelled GcvH-L and 1 µM macrodomain protein. The reactions were incubated for 1 hr at 30°C.
For the concentration gradient experiment using SauMacro and human MacroD1 reactions containing the desired final concentration of macrodomain protein were prepared and started by addition of the initial ADP-ribosylation reaction to achieve a final concentration of 1 µM SauGcvH-L in the reaction.
For the de-MARylation assay using PAR1 EQ and PARP3 self-modification was carried out in PARP buffer [50 mM TrisHCl, 50 mM NaCl, 4 mM MgCl 2 and 0.2 mM DTT] using 1 µM enzyme for 30 min at 30°C. The reaction were terminated by addition of 2 µM olaparib. activated DNA (Trevigen), 50 mM TrisHCl (pH 7.5) and 50 mM NaCl at RT. Reactions were stopped after 45 min by the addition of the PARP inhibitor KU-0058948 and were purified twice over PD SpinTrap G25 (GE Healthcare) columns to remove unbound radiolabel. Subsequently, the reactions were re-supplemented with 50 mM Tris (pH 7.5) and 50 mM NaCl and 1 μM PARG were added to the reaction. The samples were incubated for 45 min at RT.
All samples were heat-inactivated by incubating the reactions at 80°C for 5 min, spotted onto polyethyleneimine (PEI)-cellulose plates (Macherey-Nagel, Polygram CEL 300 PEI/UV 254 ) and developed in 0.2 M LiCl and 0.2 M formic acid. Dried plates were exposed on X-ray film.
NUDT16 phosphordiesterase assay
To monitor the loss of incorporated radiolabel, ADP-ribosylated GcvH-L (see above) was supplemented with 15 mM MgCl 2 and 4 µM NUDT16 and incubated for 3 hr at 30°C. Reactions were stopped with LDS sample buffer and analyzed by autoradiography and immunoblot.
NAD hydrolase activity assay
1 µM SauSirTM wt, SauSirTM N123A, SauMacro or MacroD1 was incubated with 2 μCi 32 P-NAD + , 5 μM unlabeled-NAD + in MARylation buffer at 30°C for 1 hr. The reactions were heat-inactivated by incubation at 80°C for 5 min and spotted onto polyethyleneimine (PEI)-cellulose plates (MachereyNagel, Polygram CEL 300 PEI/UV 254 ) and developed in 0.2 M LiCl and 0.2 M formic acid. Dried plates were exposed on X-ray film.
GST pull-down assays
Pull-down assays were carried out on 0.2-μm filters (Ultrafree, Millipore), using either 50 μl or 100 μl volumes in all steps. All pull-down assays were carried out at room temperature. Proteins were eluted from the beads by incubation with elution buffer for 30 min on a rotating wheel.
Samples were analyzed by immunoblot.
Crystallization
Native and selenomethionine (SeMET) labeled SpySirTM proteins for crystallization were expressed as described above and purified protein concentrated to 14 mg/ml in 25 mM TisHCl (pH 8), 100 mM NaCl and 1 mM DTT.
Initial SpySirTM crystallization conditions were identified using the Morpheus HT-96 matrix screen (Molecular dimensions). Reproducible crystallization was ensured by seeding as follows: Native SpyGcvH-L protein for crystallization was expressed as described above and purified protein concentrated to 56 mg/ml in 25 mM TisHCl (pH 8), 100 mM NaCl and 1 mM DTT. A single crystal grew at 293 K by sitting-drop vapor diffusion in a MRC 96 well plate by mixing 100 nL purified protein with 100 nL of precipitant solution consisting of 2.0 M NaH 2 PO 4 /K 2 HPO 4 (pH
